Cargando…

Advances in the use of stem cell transplants in the treatment of multiple sclerosis

Detalles Bibliográficos
Autores principales:	Thomas, Rachel, Wynford-Thomas, Ray, Robertson, Neil P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Journal Club
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782779/ https://www.ncbi.nlm.nih.gov/pubmed/34982199 http://dx.doi.org/10.1007/s00415-021-10927-6

Ejemplares similares

Amyotrophic lateral sclerosis: an update on treatments from clinical trials
por: Wynford-Thomas, Ray, et al.
Publicado: (2023)

Emerging treatments for neuromyelitis optica spectrum disorder
por: Wynford-Thomas, Ray, et al.
Publicado: (2020)

Stem cell treatment for multiple sclerosis
por: Owen Pickrell, W., et al.
Publicado: (2016)

The role of skin biopsy in differentiating idiopathic Parkinson’s disease from other types of parkinsonism
por: Wynford-Thomas, Ray, et al.
Publicado: (2015)

Long-COVID: neurological manifestations and management
por: Williams, Sioned, et al.
Publicado: (2021)

“Navigating the network”: localising the lesion with the advent of lesion network mapping
por: Sheppard, Jack, et al.
Publicado: (2023)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

B cell treatments for multiple sclerosis
por: McLauchlan, D., et al.
Publicado: (2017)

The economic burden of chronic neurological disease
por: Wynford-Thomas, R., et al.
Publicado: (2017)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

New rare genetic variants in multiple sclerosis
por: Harding, Katharine E., et al.
Publicado: (2018)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Stem cells in the treatment of central nervous system disease
por: McLauchlan, Duncan, et al.
Publicado: (2018)

Genetics of disease severity in multiple sclerosis, Alzheimer’s disease, and Huntington’s disease: rejuvenating genome-wide association studies
por: Hrastelj, James, et al.
Publicado: (2017)

Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Multiple sclerosis: early indicators of disease and assessing future risk
por: Willis, M. D., et al.
Publicado: (2020)

Ice bucket challenge bears fruit for amyotrophic lateral sclerosis
por: Hrastelj, James, et al.
Publicado: (2016)

Advances in Tourette’s syndrome
por: Robertson, Neil P.
Publicado: (2023)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2
por: Willis, M. D., et al.
Publicado: (2020)

Advances in the genetics of stroke risk and recovery
por: Majumder, Sabbiha Nadia, et al.
Publicado: (2022)

Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
por: McArthur, C., et al.
Publicado: (2023)

Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia
por: Saw, Aung M., et al.
Publicado: (2023)

Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)

An update on treatments in myasthenia gravis
por: Jones, Lliwen A., et al.
Publicado: (2016)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

New treatments in Alzheimer’s disease
por: Pickrell, William O., et al.
Publicado: (2018)

The consequences of valproate exposure in utero
por: Thomas, Rhys H., et al.
Publicado: (2016)

What can rare variant genetics tell us about cognition and intellectual difficulties?
por: Thomas, Rhys H., et al.
Publicado: (2016)

Medication-overuse headache: causes, consequences and management
por: Massey, Thomas H., et al.
Publicado: (2021)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts
por: M, Hu, et al.
Publicado: (2020)

Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for Retinitis Pigmentosa: Transplantation 2010 April 27;89 (8): 911-919
por: Sharma, Neel Kamal
Publicado: (2010)

Preclinical retinal neurodegeneration in a model of multiple sclerosis: The Journal of Neuroscience 2012; 32(16):5585–5597
por: Mathur, Deepali, et al.
Publicado: (2012)

Seizures in Alzheimer’s disease: is there more beneath the surface?
por: Edwards, Marc, et al.
Publicado: (2017)

Transmissible amyloid protein: evidence from iatrogenic CJD
por: Hu, Mo, et al.
Publicado: (2018)

Monoclonal antibodies for migraine: an update
por: Castle, Daniel, et al.
Publicado: (2018)

Treatments in Alzheimer’s disease
por: Malik, G. A., et al.
Publicado: (2017)

Deep brain stimulation for dystonia
por: Harding, Katharine E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1j4jtls7r0laakpjcag8aa15mn